Harrow (HROW) Net Equity Issued and Repurchased (2012 - 2019)
Harrow's (HROW) quarterly Net Equity Issued and Repurchased came in at -$89000.0 in Q4 2019, down 9000.0% quarter-over-quarter from $1000.0 in Q3 2018.
Harrow (HROW) Net Equity Issued and Repurchased (2012 - 2019) Analysis & Trends
Harrow's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at -$89000.0 for Q4 2019.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$89000.0 in Q4 2019; TTM through Dec 2019 was $431000.0, a 32.87% decrease from a year earlier, with the FY2023 full-year figure at $64.5 million, up 184.79% from the prior year.
- Net Equity Issued and Repurchased declined to -$89000.0 in Q4 2019 per HROW's latest filing, from $1000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $11.1 million in Q1 2016 and bottomed at -$89000.0 in Q4 2019.
- The 4-year median for Net Equity Issued and Repurchased is $195000.0 (2016), against an average of $1.8 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -89,000.00 |
| Dec 31, 2019 | -89,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 519,000.00 |
| Jun 30, 2018 | 519,000.00 |
| Mar 31, 2018 | 122,000.00 |
| Mar 31, 2018 | 122,000.00 |
| Dec 31, 2017 | 962,000.00 |
| Dec 31, 2017 | 962,000.00 |
| Sep 30, 2016 | 195,000.00 |
| Sep 30, 2016 | 195,000.00 |
| Mar 31, 2016 | 11.09 Mn |
| Mar 31, 2016 | 11.09 Mn |
| Mar 31, 2013 | 10.05 Mn |
| Mar 31, 2013 | 10.05 Mn |
| Dec 31, 2012 | -342,159.00 |
| Dec 31, 2012 | -342,159.00 |
| Sep 30, 2012 | 3.94 Mn |
| Sep 30, 2012 | 3.94 Mn |